Ilona Reischl-Kok holds a degree in pharmacy and a PhD in immunology and joined the Austrian Medicines and Medical Devices Agency (AGES MEA) in March 2006. She is affiliated with the Clinical Trials Unit since then as a quality assessor and served as head of unit until 2019.

She has been active on the European level in clinical trial and EMA working groups and currently chairs the Committee for Advanced Therapies and represented EMA in WHO ATMP activities.

She has been engaged in scientific and regulatory issues on the European level for clinical trials, biologics, ATMPs and the drug-device interface.